跳至主要内容
临床试验/ACTRN12609000512224
ACTRN12609000512224已完成1 期

Improved radiation delivery accuracy to the clinical treatment volume and concommitant reduction in incidental dose to organs-at-risk: assessment and optimisation of cone-beam computed tomography as a potential future standard of care for highly conformal radiation mono-therapy for prostate carcinoma

Perth Radiation Oncology0 个研究点目标入组 75 人开始时间: 2009年6月29日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Male

入选标准

  • Histologically confirmed prostate adenocarcinoma Localised prostate cancer of any T-stage Gleason score and Prostate Specific Antigen (PSA)
  • Planned by Computed Tomography (CT) study for radical radiotherapy that is - 7400 centigrays (cGy) in 37 fractions. Informed consents obtained for treatment and for clinical study

排除标准

  • Prior radical prostatectomy.
  • Prior high dose pelvic radiation therapy

研究者

发起方
Perth Radiation Oncology

相似试验